Department of Cancer Biology and Pharmacology, University of Illinois College of Medicine, One Illini Drive, Peoria, IL 61605, USA.
Mol Cancer. 2011 Oct 17;10:130. doi: 10.1186/1476-4598-10-130.
uPA/uPAR is a multifunctional system that is over expressed in many cancers and plays a critical role in glioblastoma (GBM) invasion. Previous studies from our lab have also shown that uPA/uPAR down regulation inhibits cancer cell invasion in SNB 19 GBM cells.
As Notch 1 is known to be over expressed and promotes invasion in glioblastoma, we therefore tested our hypothesis of whether down regulation of uPA/uPAR, singly or in tandem, attenuates GBM invasion via Notch 1 receptor. Targeted down regulation of uPA/uPAR, either singly or simultaneously, inhibited the anchorage independent growth of U251MG and GBM xenograft cell lines 4910 and 5310 as assessed by soft agar colony formation assay. Expression of all four Notch receptors was confirmed in GBM tissue array analysis by immunohistochemistry.
Down regulation of uPA/uPAR, either singly or simultaneously, in U251 MG and tumor xenografts inhibited the cleavage of the Notch receptor between the Gly 1743 and Val 1744 positions, thereby suggesting inhibition of activated cytosolic fragment-related Notch gene transcription. Morphological analysis confirmed inhibition of NICD when U251 MG cells were treated with puPA, puPAR or pU2. uPA/uPAR down regulation inhibited Notch 1 mRNA in all three examined cell lines. uPA/uPAR shRNA down regulated nuclear activation of NF-κB subunits and phosphorylation of AKT/mTOR pathway in U251 MG and GBM xenografts. puPA down regulated NICD and HES induced phosphorylation of AKT/ERK and NF-κB. Down regulation of Notch 1 using siRNA inhibited uPA activity as shown by fibrinogen zymography. It also decreased uPA expression levels as shown by western blotting. Exogenous addition of uPA activated Notch 1 in uPAR antisense U251 MG cells and also in uPAR antisense cells transfected with siRNA against Delta and Jagged. The Notch 1 receptor co-localized with LAMP-1, a marker for lysosomes in uPA, uPAR and U2, down regulated U251 MG cells which probably indicates inhibition of Notch 1 receptor trafficking in GBM cells. Notch 1 expression was significantly inhibited in puPA- and pU2-treated pre-established intracranial tumors in mice.
Overall our results show that down regulation of uPA/uPAR, either singly or simultaneously, could be an effective approach to attenuate Notch 1 receptor cleavage, signaling and endosomal trafficking in U251MG cells and xenografts, and ultimately inhibiting GBM invasion.
uPA/uPAR 是一个多功能系统,在许多癌症中过度表达,在神经胶质瘤(GBM)浸润中起着关键作用。我们实验室之前的研究还表明,uPA/uPAR 的下调抑制了 SNB19 GBM 细胞的癌细胞浸润。
已知 Notch1 在神经胶质瘤中过度表达并促进其侵袭,因此我们测试了我们的假设,即 uPA/uPAR 的下调,无论是单独还是联合下调,是否通过 Notch1 受体减弱 GBM 的侵袭。靶向下调 uPA/uPAR,无论是单独还是同时下调,均通过软琼脂集落形成试验抑制 U251MG 和 GBM 异种移植细胞系 4910 和 5310 的锚定非依赖性生长。免疫组织化学分析证实,在 GBM 组织阵列分析中,所有四个 Notch 受体的表达均得到确认。
uPA/uPAR 的下调,无论是单独还是同时下调,均可抑制 U251MG 和肿瘤异种移植中 Notch 受体在 Gly1743 和 Val1744 位置之间的裂解,从而提示对激活的胞质片段相关 Notch 基因转录的抑制。形态学分析证实,当 U251MG 细胞用 puPA、puPAR 或 pU2 处理时,NICD 受到抑制。uPA/uPAR 下调抑制了所有三种检查的细胞系中的 Notch1mRNA。uPA/uPARshRNA 下调了 U251MG 和 GBM 异种移植中 NF-κB 亚基的核激活和 AKT/mTOR 通路的磷酸化。puPA 下调 NICD 和 HES 诱导的 AKT/ERK 和 NF-κB 磷酸化。用 siRNA 下调 Notch1 如纤维蛋白原酶谱所示,可抑制 uPA 活性。它还如 Western 印迹所示降低 uPA 表达水平。外源性添加 uPA 可激活 uPAR 反义 U251MG 细胞和转染了针对 Delta 和 Jagged 的 siRNA 的 uPAR 反义细胞中的 Notch1。Notch1 受体与 LAMP-1 共定位,LAMP-1 是 uPA、uPAR 和 U2 下调的 U251MG 细胞中溶酶体的标志物,可能表明 Notch1 受体在 GBM 细胞中的运输受到抑制。在小鼠预先建立的颅内肿瘤中,puPA 和 pU2 处理后 Notch1 的表达明显受到抑制。
总的来说,我们的结果表明,uPA/uPAR 的下调,无论是单独还是同时下调,都可能是一种有效的方法,可减弱 U251MG 细胞和异种移植物中 Notch1 受体的裂解、信号转导和内体运输,并最终抑制 GBM 的浸润。